LYEL Market Cap History Table | ||||||||||||||||||||||
Also see: LYEL Shares Outstanding History and LYEL YTD Return |
LYEL Market Cap History Table | ||||||||||||||||||||||
Also see: LYEL Shares Outstanding History and LYEL YTD Return |
LYEL Market Cap History Chart | ||||||||||||||||||||||||||||||
-49.96% CAGR Mouse over chart for data details
|
LYEL Stock Price Chart |
About Lyell Immunopharma Inc |
Lyell Immunopharma is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. Co. is building a multi-modality product pipeline. Co.'s primary activities include developing T cell therapies, performing research and development, acquiring technology, entering into strategic collaboration and license arrangements, enabling manufacturing activities in support of its product candidate development efforts, organizing and staffing Co., establishing its intellectual property portfolio, regulatory submissions and other preparations to initiate clinical trials, raising capital and providing general and administrative support for these activities. We show 10 historical shares outstanding datapoints in our LYEL shares outstanding history coverage, used to compute LYEL market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LYEL market cap history over the course of time is important for investors interested in comparing LYEL's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LYEL versus a peer is one thing; comparing LYEL market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LYEL can fluctuate over the course of history. With this page we aim to empower investors researching LYEL by allowing them to research the LYEL market cap history. |
LYEL Current Stock Quote |
Free LYEL Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
LYEL Share Performance |
Market Cap Peers |
Lyell Immunopharma (LYEL) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
LYRA Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.